The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review
Open accessAbstract
IMPORTANCE: Lyme disease, human granulocytic anaplasmosis (HGA), and babesiosis are emerging tick-borne infections. OBJECTIVE: To provide an update on diagnosis, treatment, and prevention of tick-borne infections. EVIDENCE REVIEW: Search of PubMed and Scopus for articles on diagnosis, treatment, and prevention of tick-borne infections published in English from January 2005 through December 2015. FINDINGS: The search yielded 3550 articles for diagnosis and treatment and 752 articles for prevention. Of these articles, 361 were reviewed in depth. Evidence supports the use of US Food and Drug Administration-approved serologic tests, such as an enzyme immunoassay (EIA), followed by Western blot testing, to diagnose extracutaneous manifestations of Lyme disease. Microscopy and polymerase chain reaction assay of blood specimens are used to diagnose active HGA and babesiosis. The efficacy of oral doxycycline, amoxicillin, and cefuroxime axetil for treating Lyme disease has been established in multiple trials. Ceftriaxone is recommended when parenteral antibiotic therapy is recommended. Multiple trials have shown efficacy for a 10-day course of oral doxycycline for treatment of erythema migrans and for a 14-day course for treatment of early neurologic Lyme disease in ambulatory patients. Evidence indicates that a 10-day course of oral doxycycline is effective for HGA and that a 7- to 10-day course of azithromycin plus atovaquone is effective for mild babesiosis. Based on multiple case reports, a 7- to 10-day course of clindamycin plus quinine is often used to treat severe babesiosis. A recent study supports a minimum of 6 weeks of antibiotics for highly immunocompromised patients with babesiosis, with no parasites detected on blood smear for at least the final 2 weeks of treatment. CONCLUSIONS AND RELEVANCE: Evidence is evolving regarding the diagnosis, treatment, and prevention of Lyme disease, HGA, and babesiosis. Recent evidence supports treating patients with erythema migrans for no longer than 10 days when doxycycline is used and prescription of a 14-day course of oral doxycycline for early neurologic Lyme disease in ambulatory patients. The duration of antimicrobial therapy for babesiosis in severely immunocompromised patients should be extended to 6 weeks or longer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J. S., Strle, F., Stanek, G., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/508667 · Cited by 2,087
Self-citationSteere, A. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107123450207 · Cited by 1,059
Azithromycin and the Risk of Cardiovascular Death
Ray, W. A., Murray, K. T., Hall, K., Arbogast, P. G., & Stein, C. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1003833 · Cited by 954
Steere, A. C., Sikand, V. K., Meurice, F., Parenti, D. L., Fikrig, E., Schoen, R. T., Nowakowski, J., Schmid, C. H., Laukamp, S., Buscarino, C., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390401 · Cited by 746
Nocton, J. J., Dressler, F., Rutledge, B. J., Rys, P. N., Persing, D. H., & Steere, A. C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300401 · Cited by 591
Vannier, E., & Krause, P. J. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1202018 · Cited by 573
Self-citationNadelman, R. B., Nowakowski, J., Fish, D., Falco, R. C., Freeman, K., McKenna, D., Welch, P., Marcus, R., Agüero-Rosenfeld, M. E., Dennis, D. T., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107123450201 · Cited by 508
Self-citationBabesiosis: Recent insights into an ancient disease
HUNFELD, K., HILDEBRANDT, A., & GRAY, J. (2008) · International Journal for Parasitology · doi:10.1016/j.ijpara.2008.03.001 · Cited by 447
Humans Infected with Relapsing Fever Spirochete Borrelia miyamotoi, Russia
Platonov, A. E., Karan, L. S., Kolyasnikova, N. M., Makhneva, N. A., Toporkova, M. G., Maleev, V. V., Fish, D., & Krause, P. J. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.101474 · Cited by 436
Human Granulocytic Anaplasmosis
Bakken, J. S., & Dumler, J. S. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.02.007 · Cited by 429
Chapman, A. S., Bakken, J., Folk, S. M., Paddock, C. D., Bloch, K. C., Krusell, A., Sexton, D. J., Buckingham, S. C., Marshall, G. S., Storch, G. A., et al. (2006) · PubMed · Cited by 427
Atovaquone and Azithromycin for the Treatment of Babesiosis
Krause, P. J., Lepore, T., Sikand, V. K., Gadbaw, J., Burke, G., Telford, S. R., Brassard, P., Pearl, D., Azlanzadeh, J., Christianson, D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432004 · Cited by 381
Pritt, B. S., Mead, P. S., Johnson, D. K. H., Neitzel, D. F., Respicio-Kingry, L. B., Davis, J. P., Schiffman, E., Sloan, L. M., Schriefer, M. E., Replogle, A. J., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00464-8 · Cited by 355
Persistent and Relapsing Babesiosis in Immunocompromised Patients
Krause, P. J., Gewurz, B. E., Hill, D., Marty, F. M., Vannier, E., Foppa, I. M., Furman, R. R., Neuhaus, E., Skowron, G., Gupta, S., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525852 · Cited by 349
Self-citationWormser, G. P., Ramanathan, R., Nowakowski, J., McKenna, D., Holmgren, D., Visintainer, P., Dornbush, R., Singh, B., & Nadelman, R. B. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-9-200305060-00005 · Cited by 296
Self-citationBacon, R. M., Biggerstaff, B. J., Schriefer, M. E., Gilmore, Jr., Philipp, M. T., Steere, A. C., Wormser, G. P., Marques, A. R., & Johnson, B. J. B. (2003) · The Journal of Infectious Diseases · doi:10.1086/374395 · Cited by 290
Self-citationPersistent Parasitemia after Acute Babesiosis
Krause, P. J., Spielman, A., Telford, S. R., Sikand, V. K., McKay, K., Christianson, D., Pollack, R. J., Brassard, P., Magera, J., Ryan, R., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807163390304 · Cited by 288
Emergence of a New Pathogenic Ehrlichia Species, Wisconsin and Minnesota, 2009
Pritt, B. S., Sloan, L. M., Johnson, D. K. H., Munderloh, U. G., Paskewitz, S. M., McElroy, K. M., McFadden, J. D., Binnicker, M. J., Neitzel, D. F., Liu, G., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010493 · Cited by 287
Prospective Study of Serologic Tests for Lyme Disease
Steere, A. C., McHugh, G., Damle, N., & Sikand, V. K. (2008) · Clinical Infectious Diseases · doi:10.1086/589242 · Cited by 279
Meningoencephalitis from Borrelia miyamotoi in an Immunocompromised Patient
Gugliotta, J. L., Goethert, H. K., Berardi, V. P., & Telford, S. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209039 · Cited by 278
Ljøstad, U., Skogvoll, E., Eikeland, R., Midgard, R., Skarpaas, T., Berg, Å., & Mygland, Å. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70119-4 · Cited by 275
Krause, P. J., McKay, K., Thompson, C. A., Sikand, V. K., Lentz, R., Lepore, T., Closter, L., Christianson, D., Telford, S. R., Persing, D., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339813 · Cited by 273
Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness
Krause, P. J. (1996) · JAMA · doi:10.1001/jama.275.21.1657 · Cited by 266
Human Borrelia miyamotoi Infection in the United States
Krause, P. J., Narasimhan, S., Wormser, G. P., Rollend, L., Fikrig, E., Lepore, T., Barbour, A., & Fish, D. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1215469 · Cited by 242
Self-citationInfection with a Babesia-Like Organism in Northern California
Persing, D. H., Herwaldt, B. L., Glaser, C. A., Lane, R. S., Thomford, J. W., Mathiesen, D. A., Krause, P. J., Phillip, D. F., & Conrad, P. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320504 · Cited by 238
Diagnosis and Treatment of Lyme Arthritis
Arvikar, S. L., & Steere, A. C. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.02.004 · Cited by 229
Comparison of Cefuroxime Axetil and Doxycycline in the Treatment of Early Lyme Disease
Nadelman, R. B., Luger, S. W., Frank, E., Wisniewski, M., Collins, J. J., & Wormser, G. P. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-273 · Cited by 219
Self-citationPeridomestic Lyme Disease Prevention
Connally, N. P., Durante, A. J., Yousey-Hindes, K. M., Meek, J. I., Nelson, R. S., & Heimer, R. (2009) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2009.04.026 · Cited by 174
Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis
Dattwyler, R. J., Volkman, D. J., Conaty, S. M., Platkin, S. P., & Luft, B. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)93103-v · Cited by 165
Branda, J. A., Linskey, K., Kim, Y. A., Steere, A. C., & Ferraro, M. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir464 · Cited by 164
Effectiveness of Personal Protective Measures to Prevent Lyme Disease
Vázquez, M., Muehlenbein, C., Cartter, M., Hayes, E. B., Ertel, S., & Shapiro, E. D. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1402.070725 · Cited by 163
High frequency of false positive IgM immunoblots for Borrelia burgdorferi in Clinical Practice
Seriburi, V., Ndukwe, N., Chang, Z., Cox, M. E., & Wormser, G. P. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03749.x · Cited by 160
Self-citationSingle-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease
Wormser, G. P., Schriefer, M., Aguero-Rosenfeld, M. E., Levin, A., Steere, A. C., Nadelman, R. B., Nowakowski, J., Marques, A., Johnson, B. J. B., & Dumler, J. S. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.09.003 · Cited by 160
Self-citationComparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis
Karlsson, M., Hammers-Berggren, S., Lindquist, L., Stiernstedt, G., & Svenungsson, B. (1994) · Neurology · doi:10.1212/wnl.44.7.1203 · Cited by 158
Häselbarth, K., Tenter, A. M., Brade, V., Krieger, G., & Hunfeld, K.-P. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.01.002 · Cited by 157
Effectiveness of Residential Acaricides to Prevent Lyme and Other Tick-borne Diseases in Humans
Hinckley, A. F., Meek, J. I., Ray, J. A., Niesobecki, S. A., Connally, N. P., Feldman, K. A., Jones, E. H., Backenson, P. B., White, J. L., Lukacik, G., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv775 · Cited by 142
Diagnostic challenges of early Lyme disease: Lessons from a community case series
Aucott, J. N., Morrison, C., Muñoz, B., et al. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-79 · Cited by 139
Luger, S. W., Paparone, P. W., Wormser, G. P., et al. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.661 · Cited by 133
Self-citationHALPERIN, J. J. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.02.002 · Cited by 131
Borrelia miyamotoisensu lato Seroreactivity and Seroprevalence in the Northeastern United States
Krause, P. J., Narasimhan, S., Wormser, G. P., Barbour, A. G., Platonov, A. E., Brancato, J., Lepore, T. J., Dardick, K. R., Mamula, M. J., Rollend, L., et al. (2014) · Emerging infectious diseases · doi:10.3201/eid2007.131587 · Cited by 126
Self-citationSerial Measurements of Hematologic Counts during the Active Phase of Human Granulocytic Ehrlichiosis
Bakken, J., Aguero-Rosenfeld, M. E., Tilden, R. L., Wormser, G. P., Horowitz, H. W., Raffalli, J. T., Baluch, M., Riddell, D., Walls, J. J., & Dumler, J. S. (2001) · Clinical Infectious Diseases · doi:10.1086/319350 · Cited by 122
Self-citationSuccessful Oral Doxycycline Treatment of Lyme Disease‐Associated Facial Palsy and Meningitis
Dotevall, L., & Hagberg, L. (1999) · Clinical Infectious Diseases · doi:10.1086/515145 · Cited by 110
Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis
Borg, R., Dotevall, L., Hagberg, L., Maraspin, V., Lotrič‐Furlan, S., Cimperman, J., & Strle, F. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540510027228 · Cited by 107
Kowalski, T. J., Tata, S., Berth, W., Mathiason, M. A., & Agger, W. A. (2010) · Clinical Infectious Diseases · doi:10.1086/649920 · Cited by 106
Belongia, E. A., Reed, K. D., Mitchell, P. D., Chyou, P.-H., Mueller‐Rizner, N., Finkel, M. F., & Schriefer, M. E. (1999) · Clinical Infectious Diseases · doi:10.1086/313532 · Cited by 104
Hytönen, J., Kortela, E., Waris, M. E., Puustinen, J., Salo, J., & Oksi, J. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-103 · Cited by 102
Branda, J. A., Aguero‐Rosenfeld, M. E., Ferraro, M. J., Johnson, B. J. B., Wormser, G. P., & Steere, A. C. (2009) · Clinical Infectious Diseases · doi:10.1086/648674 · Cited by 102
Self-citationCSF B – lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis
Ljøstad, U., & Mygland, Å. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0785-y · Cited by 95
Notifiable Diseases and Mortality Tables.
(2016) · PubMed · Cited by 94
Atovaquone in the Treatment of Babesia microti Infections in Hamsters
Wittner, M., Lederman, J. A., Tanowitz, H. B., et al. (1996) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1996.55.219 · Cited by 89
Azithromycin and doxycycline for treatment ofBorrelia culture-positive erythema migrans
Strle, F., Cimperman, J., Maraspin, V., et al. (1996) · Infection · doi:10.1007/bf01780661 · Cited by 84
Khoury, M. Y. E., Camargo, J. F., White, J. L., Backenson, B. P., Dupuis, A. P., Escuyer, K. L., Kramer, L. D., George, K. S., Chatterjee, D., Prusinski, M. A., et al. (2013) · Emerging infectious diseases · doi:10.3201/eid1912.130903 · Cited by 80
Self-citationImproved Culture Conditions for the Growth and Detection of Borrelia from Human Serum
Sapi, E., Pabbati, N., Datar, A., Davies, E. M., Rattelle, A., & Kuo, B. A. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.5698 · Cited by 79
Human Granulocytic Ehrlichiosis During Pregnancy Treated Successfully with Rifampin
Buitrago, M. I., IJdo, J. W., Rinaudo, P. F., Simon, H., Copel, J., Gadbaw, J., Heimer, R., Fikrig, E., & Bia, F. J. (1998) · Clinical Infectious Diseases · doi:10.1086/517678 · Cited by 75
Forrester, J. D., Meiman, J. G., Mullins, J., Nelson, R., Ertel, S.-H., Cartter, M., Brown, C., Lijewski, V. A., Schiffman, E. K., Neitzel, D. F., et al. (2014) · PubMed Central · Cited by 75
The Importance of Early Treatment With Doxycycline in Human Ehrlichiosis
Hamburg, B. J., Storch, G. A., Micek, S. T., & Kollef, M. H. (2008) · Medicine · doi:10.1097/md.0b013e318168da1d · Cited by 74
Successful Treatment of Human Granulocytic Ehrlichiosis in Children Using Rifampin
Krause, P. J., Corrow, C. L., & Bakken, J. (2003) · PEDIATRICS · doi:10.1542/peds.112.3.e252 · Cited by 74
Fallon, B. A., Pavlicová, M., Coffino, S., & Brenner, C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu703 · Cited by 70
Solberg, V. B., Miller, J. A., Hadfield, T. L., Burge, R., Schech, J. M., & Pound, J. M. (2003) · PubMed · Cited by 67
HALPERIN, J. J. (2015) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2015.07.002 · Cited by 66
Lyme Disease: Laboratory Issues
Aguero‐Rosenfeld, M. E. (2008) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2007.12.005 · Cited by 66
Porwancher, R. B., Hagerty, C., Fan, J., Landsberg, L., Johnson, B. J. B., Kopnitsky, M. J., Steere, A. C., Kulas, K. E., & Wong, S. J. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00409-10 · Cited by 66
Utilization of a real-time PCR assay for diagnosis of Babesia microti infection in clinical practice
Wang, G., Wormser, G. P., Zhuge, J., Villafuerte, P., Ip, D., Zeren, C., & Fallon, J. T. (2015) · Ticks and Tick-borne Diseases · doi:10.1016/j.ttbdis.2015.03.001 · Cited by 65
Self-citationWormser, G. P., Nowakowski, J., Nadelman, R. B., Visintainer, P., Levin, A. E., & Aguero‐Rosenfeld, M. E. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00109-08 · Cited by 60
Self-citationDiagnosis of Human Granulocytic Ehrlichiosis: State of the Art
Aguero‐Rosenfeld, M. E. (2002) · Vector-Borne and Zoonotic Diseases · doi:10.1089/153036602321653815 · Cited by 58
Wormser, G. P., Levin, A. E., Soman, S., Adenikinju, O., Longo, M. V., & Branda, J. A. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01853-13 · Cited by 58
Self-citationMarques, A. R., Brown, M. R., & Fleisher, T. A. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00167-09 · Cited by 58
Lantos, P. M., Branda, J., Boggan, J., Chudgar, S., Wilson, E. A., Ruffin, F., Fowler, V., Auwaerter, P., & Nigrovic, L. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ584 · Cited by 53
Vyas, J. M., Telford, S. R., & Robbins, G. K. (2007) · Clinical Infectious Diseases · doi:10.1086/523731 · Cited by 47
Wang, G., Villafuerte, P., Zhuge, J., Visintainer, P., & Wormser, G. P. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.03.010 · Cited by 45
Self-citationSchriefer, M. E. (2015) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2015.08.001 · Cited by 37
Wormser, G. P., Aguero‐Rosenfeld, M. E., Cox, M. E., Nowakowski, J., Nadelman, R. B., Holmgren, D., McKenna, D. F., Bittker, S. J., Zentmaier, L., Cooper, D., et al. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02929-12 · Cited by 36
Self-citationSolitary erythema migrans in children: comparison of treatment with clarithromycin and amoxicillin
Nizič, T., Velikanje, E., Ružić‐Sabljić, E., et al. (2012) · Wiener klinische Wochenschrift · doi:10.1007/s00508-012-0194-1 · Cited by 32
Wroblewski, H. A., Kovacs, R. J., Kingery, J. R., Overholser, B. R., & Tisdale, J. E. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06396-11 · Cited by 27
Azithromycin Is Equally Effective as Amoxicillin in Children with Solitary Erythema Migrans
Arnež, M., & Ružić‐Sabljić, E. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000804 · Cited by 20
Cited by
Steere, A. C., Strle, F., Wormser, G. P., Hu, L. T., Branda, J. A., Hovius, J. W. R., Li, X., & Mead, P. S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.90 · Cited by 845
Self-citationMadison-Antenucci, S., Kramer, L. D., Gebhardt, L. L., & Kauffman, E. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00083-18 · Cited by 586
Lantos, P. M., Rumbaugh, J., Bockenstedt, L. K., Falck-Ytter, Y. T., Aguero-Rosenfeld, M. E., Auwaerter, P. G., Baldwin, K., Bannuru, R. R., Belani, K. K., Bowie, W. R., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1215 · Cited by 376
Self-citationLyme borreliosis–from tick bite to diagnosis and treatment
Stanek, G., & Strle, F. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux047 · Cited by 265
Lyme disease overdiagnosis in a large healthcare system: a population-based, retrospective study
Webber, B. J., Burganowski, R. P., Colton, L., Escobar, J. D., Pathak, S. R., & Gambino-Shirley, K. J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.02.020 · Cited by 57
Metadata
- Authors
- Sanchez, E., Vannier, E., Wormser, G. P., & Hu, L. T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-04-26
- Volume
- 315
- Issue
- 16
- Pages
- 1767
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2344599923
- Cited by
- 337
- References
- 76
- FWCI
- 35.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.